Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (351)
ARTG (709)
Prescription medicine registration (62)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian public assessment report (AusPar) (6)
Prescription medicine decision summary (1)

Date

2025 (20)
2024 (62)
2023 (14)
2022 (17)
2021 (71)
2020 (71)
2019 (29)
2018 (30)
2017 (30)
2015 (7)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

351 result(s) found, displaying 1 to 10

RASAGILINE SANDOZ rasagiline (as mesilate) 1 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
GEMCITABINE EBEWE gemcitabine (as hydrochloride) 200 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
GEMCITABINE EBEWE gemcitabine (as hydrochloride) 1000 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMOXICILLIN/CLAVULANIC ACID VIATRIS 500/125 amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMOXICILLIN/CLAVULANIC ACID VIATRIS 875/125 amoxicillin 875 mg (as trihydrate) and clavulanic acid 125 mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
Paracetamol Sandoz (paracetamol) 10mg/mL solution for infusion 100mL glass vial Cancelled under Section 30(1)(c) of the Act

28 March 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FLUCONAZOLE SANDOZ fluconazole 400 mg/200 mL injection vial Cancelled under Section 30(1)(c) of the Act

6 February 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FLUCONAZOLE SANDOZ fluconazole 200 mg/100 mL injection vial Cancelled under Section 30(1)(c) of the Act

6 February 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FLUCONAZOLE SANDOZ fluconazole 100 mg/50 mL injection vial Cancelled under Section 30(1)(c) of the Act

6 February 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd
VARENICLINE SANDOZ varenicline (as citrate) 1.0 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 January 2025

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.